With Dr Ronjon Nag and Martin Hunt.
Evidencing long-term value to funders as well as patients and clinicians.
In the last episode we discussed the different types of funding, what investors are looking for, and what developers should understand to attract investment. In this episode, we continued the conversation with Ronjon and Martin on what comes next: how you can build your team and scale up or expand once you’ve seen real patient benefits, and what comes at the end of the journey.
Over the life cycle of a company there will be different requirements and teams may need to reconfigure, adjust and grow. Based on risk, a company’s needs begin to change and develop, but at an early stage, with a lack of data or experience, it will be difficult to make these decisions. Can this challenge be mitigated? Funding is vital throughout a company or product life cycle, not just at the beginning. How can you ensure your new technology is attractive to investors throughout the entire process? Listen to this week’s episode to learn more.